Nuplazid 34 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FQLN0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,530
Award facts
- Contract value 100% obligated
- $3,529.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,529.63 to DMS Pharmaceutical Group Inc. for 30-count bottles of Nuplazid 34 mg capsules, with a completion date of January 15, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a firm fixed-price purchase issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency.
This delivery order falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract awarded November 13, 2025, with completion targeted for December 31, 2036. The PPV-G GEN V represents part of a broader $30.3 billion Defense Logistics Agency acquisition strategy to establish regional pharmaceutical prime vendor contractors supporting Department of Defense healthcare operations globally. DMS Pharmaceutical Group's established performance on numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of military healthcare facilities worldwide, with its product portfolio encompassing branded and generic prescription medications, biologics, vaccines, and medical consumables across multiple therapeutic categories.
Quick answers
Who was awarded contract SPE2DR26FQLN0?
SPE2DR26FQLN0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26FQLN0 worth?
The government has obligated $3,530 on SPE2DR26FQLN0.
Is contract SPE2DR26FQLN0 an order under another contract?
Yes. SPE2DR26FQLN0 is a delivery order under SPE2DR25D9354, an indefinite delivery contract.
Was contract SPE2DR26FQLN0 competed?
The extent of competition for SPE2DR26FQLN0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award